Pulmonary Arterial Hypertension Associated with Congenital Heart Disease, also known as pah associated with congenital heart disease, is related to pulmonary hypertension, primary, 1 and pulmonary hypertension. An important gene associated with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease is BMPR2 (Bone Morphogenetic Protein Receptor Type 2), and among its related pathways/superpathways are DREAM Repression and Dynorphin Expression and Human Embryonic Stem Cell Pluripotency. The drugs Captopril and Spironolactone have been mentioned in the context of this disorder. Affiliated tissues include heart and smooth muscle, and related phenotypes are Increased shRNA abundance (Z-score > 2) and normal